S. Mejía

发表

STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).

Diego F. Chamorro, M. Burotto, R. Rosell, 2022, Lung cancer.

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

R. Rosell, A. Cardona, L. Raez, 2023, Targeted Oncology.

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country

R. Rosell, A. Cardona, O. Arrieta, 2023, Cancer control : journal of the Moffitt Cancer Center.

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).

M. Burotto, R. Rosell, A. Cardona, 2022, Clinical lung cancer.